ID: ALA4594196

Max Phase: Preclinical

Molecular Formula: C31H23N3O4

Molecular Weight: 501.54

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  O=C(Cn1cc(C#Cc2ccc3c4cccc5cccc(c6cccc2c63)c54)c(=O)[nH]c1=O)NCCCO

Standard InChI:  InChI=1S/C31H23N3O4/c35-16-4-15-32-27(36)18-34-17-21(30(37)33-31(34)38)12-11-19-13-14-26-24-9-2-6-20-5-1-8-23(28(20)24)25-10-3-7-22(19)29(25)26/h1-3,5-10,13-14,17,35H,4,15-16,18H2,(H,32,36)(H,33,37,38)

Standard InChI Key:  BVRBKGHAECDLAJ-UHFFFAOYSA-N

Associated Targets(Human)

RD 1212 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Tick-borne encephalitis virus 132 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Vero 26788 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Enterovirus A71 1246 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Poliovirus 1 1274 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Echovirus 56 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 501.54Molecular Weight (Monoisotopic): 501.1689AlogP: 3.49#Rotatable Bonds: 5
Polar Surface Area: 104.19Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 9.48CX Basic pKa: CX LogP: 2.94CX LogD: 2.93
Aromatic Rings: 6Heavy Atoms: 38QED Weighted: 0.15Np Likeness Score: -0.57

References

1. Chistov AA, Orlov AA, Streshnev PP, Slesarchuk NA, Aparin IO, Rathi B, Brylev VA, Kutyakov SV, Mikhura IV, Ustinov AV, Westman G, Palyulin VA, Jain N, Osolodkin DI, Kozlovskaya LI, Korshun VA..  (2019)  Compounds based on 5-(perylen-3-ylethynyl)uracil scaffold: High activity against tick-borne encephalitis virus and non-specific activity against enterovirus A.,  171  [PMID:30909022] [10.1016/j.ejmech.2019.03.029]

Source